NEWYou can now listen to Fox News articles! Chronic kidney disease has been named the ninth leading cause of global death. Record numbers of men and women are currently estimated to have reduced kidney function, according to new research following a study published in the journal The Lancet. Researchers at NYU Langone Health, the University…
NEWYou can now listen to Fox News articles! With new agreements from President Donald Trump promising lower prices on popular weight-loss drugs, the use of GLP-1 medications such as Ozempic and Mounjaro could soon surge even higher — a trend already spreading unevenly across the U.S., with some states seeing greater uptick than others. Based…
NEWYou can now listen to Fox News articles! With new agreements from President Donald Trump promising lower prices on popular weight-loss drugs, the use of GLP-1 medications such as Ozempic and Mounjaro could soon surge even higher — a trend already spreading unevenly across the U.S., with some states seeing greater uptick than others. Based…
Eli Lilly shares jumped Thursday after the drugmaker posted a strong third quarter, driven by sales of its popular GLP-1 medications. The company also raised its full-year sales outlook for the second time in a row, inspiring confidence in the trajectory of the franchise. Revenue in the three months ended Sept. 30 jumped 54% year…
NEWYou can now listen to Fox News articles! For decades, BMI (body mass index) has been the go-to number doctors use to decide whether someone is underweight, “normal,” overweight or obese. But new global research suggests it’s possible to have a normal BMI, look thin in clothes and still meet the medical definition of obesity….
NEWYou can now listen to Fox News articles! Popular drugs credited with shrinking waistlines and controlling blood sugar may also take the edge off alcohol’s buzz, according to a new study. Researchers at Virginia Tech’s Fralin Biomedical Research Institute analyzed how 20 adults with obesity — half of whom had been taking GLP-1 receptor agonists…
